Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Publicover

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Medicine (London, England)|May 18, 2013
Myeloproliferative neoplasmsAmy Publicover, Patrick Medd
British Journal of Haematology|February 3, 2015
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplantsLaura Jardine, Amy Publicover, Venetia Bigley, et al.
Theranostics|February 8, 2014
Biosimilar G-CSF based mobilization of peripheral blood hematopoietic stem cells for autologous and allogeneic stem cell transplantationMichael Schmitt, Amy Publicover, Kim H Orchard, et al.
British Journal of Haematology|April 26, 2013
Use of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftmentAmy Publicover, Deborah S Richardson, Andrew Davies, et al.
British Journal of Haematology|January 9, 2026
Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantationMaymoon M Madkhali, Alex Mitchell, Callum Wright, et al.
The Journal of Clinical Investigation|May 27, 2020
Donor monocyte-derived macrophages promote human acute graft-versus-host diseaseLaura Jardine, Urszula Cytlak, Merry Gunawan, et al.
Blood Advances|October 25, 2019
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemiaPaul Milne, Charlotte Wilhelm-Benartzi, Michael R Grunwald, et al.
Plos One|October 23, 2015
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease DiagnosisSuzanne E Brooks, Stephanie A Bonney, Cindy Lee, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Medicine (London, England)|May 18, 2013
Myeloproliferative neoplasmsAmy Publicover, Patrick Medd
British Journal of Haematology|February 3, 2015
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplantsLaura Jardine, Amy Publicover, Venetia Bigley, et al.
Theranostics|February 8, 2014
Biosimilar G-CSF based mobilization of peripheral blood hematopoietic stem cells for autologous and allogeneic stem cell transplantationMichael Schmitt, Amy Publicover, Kim H Orchard, et al.
British Journal of Haematology|April 26, 2013
Use of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftmentAmy Publicover, Deborah S Richardson, Andrew Davies, et al.
British Journal of Haematology|January 9, 2026
Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantationMaymoon M Madkhali, Alex Mitchell, Callum Wright, et al.
The Journal of Clinical Investigation|May 27, 2020
Donor monocyte-derived macrophages promote human acute graft-versus-host diseaseLaura Jardine, Urszula Cytlak, Merry Gunawan, et al.
Blood Advances|October 25, 2019
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemiaPaul Milne, Charlotte Wilhelm-Benartzi, Michael R Grunwald, et al.
Plos One|October 23, 2015
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease DiagnosisSuzanne E Brooks, Stephanie A Bonney, Cindy Lee, et al.
Pageof 1